Thirty companies and academic groups will receive the same set
of tumor samples from individual patients and will try to predict the best neoantigens.
«Furthermore, analysis
of tumor samples from large cohorts of colorectal cancer patients revealed that activation of the loop is associated with metastasis,» Hermeking reports.
A multicenter team of researchers reports that a full genomic analysis
of tumor samples from a small number of people who died of pancreatic cancer suggests that chemical changes to DNA that do not affect the DNA sequence itself yet control how it operates confer survival advantages on subsets of pancreatic cancer cells.
The finding, reported by a Stand Up to Cancer - Prostate Cancer Foundation Dream Team in the May 21 edition of the journal Cell, is based on an analysis
of tumor samples from 150 men with metastatic prostate cancer that no longer responded to standard hormone - blocking therapy.
She has sequenced hundreds
of tumor samples from across the island in an effort to understand how it evolves and how that affects the devils» survival rates.
Not exact matches
To determine how the cells switch
from one type to another, they took three human uterine carcinosarcoma
samples and sequenced the genomes
of cells in two parts
of each
tumor: the carcinoma and sarcoma components.
For example, TCGA, with genomic data on 33
tumor types taken
from samples from 11,000 patients, is finishing 2018 by publishing a series
of papers and holding a symposium.
The focus
of those hopes is the liquid biopsy: a test that could detect and analyze a solid
tumor from biomarkers in the bloodstream or other easily
sampled body fluids, such as saliva.
Even after initial purification
of the
sample, liquid biopsies typically contain much more nucleic acid
from healthy cells than
from tumors.
HBI member V. Wee Yong, PhD and research associate Susobhan Sarkar, PhD, and their team including researchers
from the Department
of Clinical Neurosciences and the university's Southern Alberta Cancer Research Institute, looked at human brain
tumor samples and discovered that specialized immune cells in brain
tumor patients are compromised.
In blood
samples from 1005 patients with eight types
of tumors that had evidently not yet metastasized, the test detected between 33 % and 98 %
of cases, depending on the
tumor type (see graph, above).
31: The percentage
of genetic mutations shared by all the
tumor samples taken
from a patient with kidney cancer.
«This gives us novel and exciting new therapeutic options to pursue based on results
from drug screenings
of primary
tumor samples from patients.»
Researchers said the importance
of collecting tissue
samples from recurrent
tumors will grow as more targeted therapies become available.
To that end, in collaboration with the University
of Zurich and MD Anderson Cancer Center, the researchers tested melanoma
tumor samples from human patients undergoing treatment with the same targeted therapies.
The investigators looked at 4,278
tumor samples from a tissue repository
of patients with GI tract cancers.
Spearheaded by first author Christopher McNair, PhD, a graduate student in the laboratory
of Dr. Knudsen, the study undertook an extensive analysis
of tumor samples and cell - free DNA
samples from patients with advanced, lethal - stage prostate cancer.
Using
tumor samples from a patient, they do lab tests to determine which substances can first make the different types
of cancer cells uniform and then effectively kill them.
A global analysis
of metabolites and small molecules in urine
samples from patients with adrenal cancer has identified four biochemicals that, when measured together, can distinguish malignant
from benign adrenal
tumors, according to study results presented at the 2015 Annual Clinical Congress
of the American College
of Surgeons.
Analysis
of blood and tissue
samples from one patient revealed that plakoglobin was expressed in CTC clusters but not single CTCs and also was expressed in some portions
of both the primary
tumor and metastases.
Using
tumor samples from the Women's Healthy Eating and Living clinical trial, researchers identified stem - like
tumor cells as being characterized by low levels
of the molecule p53 upregulated modulator
of apoptosis (PUMA).
From tissue and cell samples from five glioblastoma patients, the scientists obtained 33 individual cancer cells capable of reproduction, which grew into very different tumors in the
From tissue and cell
samples from five glioblastoma patients, the scientists obtained 33 individual cancer cells capable of reproduction, which grew into very different tumors in the
from five glioblastoma patients, the scientists obtained 33 individual cancer cells capable
of reproduction, which grew into very different
tumors in the lab.
A total
of 67 biochemical features discriminated cancer
from benign
tumors in these
samples, but only four specific metabolites could be considered as biomarkers for cancer: creatinine riboside, tryptophan, Nε, Nε, Nε - trimethyllysine, and 3 - methylhistidine.
A new investigation
of more than 48,000 stored
tumor samples finds evidence
of a key deficiency in a repair mechanism designed to keep DNA
from being mutated and causing cancer.
To see whether Lin28 might be a factor in Wilms
tumor development, Daley and an international team
of collaborators measured the gene's expression in
tumor samples from 105 Wilms patients.
To streamline this process, Uhlén's team has created standardized arrays containing microscopic
samples from 48 kinds
of normal human tissue and 20 types
of tumors.
To better understand the formation
of metastases in pancreatic cancer, Christine Iacobuzio - Donahue, M.D., Ph.D., professor
of pathology at Memorial Sloan Kettering Cancer Center, collected
tumor samples from eight patients with the most common form
of pancreatic cancer (pancreatic ductal adenocarcinoma) immediately after their deaths.
The researchers next will turn to analyzing the presence
of myoferlin in
samples from numerous human
tumor types available in an Ohio State tissue bank, which will allow them to compare protein levels in
tumors to clinical outcomes for the patients who provided the
samples.
Unlike other solid
tumors, there has been limited progress in understanding the contribution
of genetic risk factors to the development
of uveal melanoma, researchers say, primarily due to the absence
of comprehensive genetic data
from patients as the large
sample cohorts for this rare cancer type have not been available for research.
«In the
tumor sample from a patient with high NRP - 1 expression, there was a significant improvement in the efficacy
of the nanoparticle to induce
tumor shrinkage,» said Nel.
Using all the existing data that was available, Andrechek, along with MSU doctoral student Daniel Hollern, analyzed 1,172 mouse mammary
tumor samples from 26 different preclinical models and was able to compile one
of the largest databases to show which strains
of mice were best suited to study a particular type
of human breast cancer.
Analyzing the poly - G profiles
of primary and metastatic colon cancer
samples from 22 patients revealed that how the primary and metastatic
tumors related to each other was different for each patient.
Cells were extracted
from the biopsy
of her
tumor sample for use in research without her knowledge or consent.
Answering important clinical questions — such as whether genetic diversity is a risk factor for aggressive
tumor development or how it relates to treatment resistance — requires analyzing
samples from many patients with different types
of cancer.
The researchers were able to replicate this finding by comparing the healthy thyroid tissues in GTEx to 500
samples taken
from thyroid
tumors, compiled by The Cancer Genome Atlas, and giving support to the extensive impact
of FOXE1 on cellular state.
The total environmental DNA
of grape crown gall
tumor disease is revealed in the genetic profile based on 52 tissue
samples of crown gall
tumor taken
from 16 grapevine species.
Information obtained via single - cell sequencing
from cells
sampled from each core indicate the likely location
of a cancerous
tumor (dotted lines encompassing cores 2, 3 and 6).
To confirm that the missing mutations were important for generating an immune response, the researchers cultured a subset
of the neoantigen protein fragments containing the
tumor mutations with immune cells taken
from three patients» blood
samples.
Analysis
of liver
tumor samples from patients showed that NRF2 expression correlated with
tumor metastasis.
Working in mouse models
of breast cancer and breast
tumor samples from patients, Longmore and his colleagues showed that a protein that sits on the surface
of tumor cells, called DDR2, binds to collagen and activates a multistep pathway that encourages
tumor cells to spread.
To search for other characteristics
of ccRCC
tumors that influences immunotherapy response or resistance, the researchers used whole - exome DNA sequencing to analyze
tumor samples from 35 patients treated in a clinical trial with the checkpoint blocker nivolumab (Opdivo).
Researchers also can't draw inferences
from a single
sample on the frequency
of tumors in the Neandertal population, he says.
In the first cohort, researchers led by Jeeyun Lee, MD,
from Sungkyunkwan University School
of Medicine in Seoul, performed whole exome sequencing on
samples from paired synchronous primary and metastatic
tumors.
The researchers used an enhanced version
of a technique they developed called CAPP - Seq to isolate and sequence circulating
tumor DNA, or ctDNA,
from blood
samples from the patients.
Overall, including all genomic variations present in most if not all
tumor cells (clonal) as well as those present only in subsets
of the cancer cells (subclonal)
from tumor tissue, the researchers detected a total
of 864 genetic changes in tissue
samples across the three
tumor types, and 627 (73 %)
of those were also found in the blood.
In a landmark paper, Cancer Research UK funded scientists alongside an international team
of researchers read all
of the DNA in
tumor samples from 10 men with prostate cancer.
In collaboration with Dr. Omer Iqbal,
from the Department
of Pathology, they are analyzing the genetics and biology
of tumor samples to find how they differ
from samples of tumors not linked to radiation.
Searching for T cells that had infiltrated the
tumors, they collected as many as 50 T cell
samples from a single
tumor; next, the team tested each batch
of T cells against other
tumor samples from the same patient.
Notably, the researchers found that, using their methods, highly reactive TILs could be obtained
from some 90 %
of the ovarian cancer patients whose
tumor samples they examined.
Charles Swanton, a cancer geneticist at the Francis Crick Institute in London, and colleagues analyzed 1,206 clear - cell renal cell carcinoma (ccRCC)
tumor samples from 101 patients as part
of the Tracking Cancer Evolution through therapy (TRACERx) program.